Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022

Loading...
Loading...

Upgrades

  • According to Roth Capital, the prior rating for Amplify Energy Corp AMPY was changed from Neutral to Buy. For the second quarter, Amplify Energy had an EPS of $0.73, compared to year-ago quarter EPS of $0.92. The current stock performance of Amplify Energy shows a 52-week-high of $9.86 and a 52-week-low of $3.10. Moreover, at the end of the last trading period, the closing price was at $9.39.
  • According to Barclays, the prior rating for Intel Corp INTC was changed from Underweight to Equal-Weight. For the third quarter, Intel had an EPS of $0.59, compared to year-ago quarter EPS of $1.71. The stock has a 52-week-high of $56.28 and a 52-week-low of $24.59. At the end of the last trading period, Intel closed at $26.27.
  • Wolfe Research upgraded the previous rating for First Solar Inc FSLR from Peer Perform to Outperform. For the third quarter, First Solar had an EPS of $0.46, compared to year-ago quarter EPS of $0.42. The stock has a 52-week-high of $145.74 and a 52-week-low of $59.60. At the end of the last trading period, First Solar closed at $131.18.
  • According to Piper Sandler, the prior rating for Gilead Sciences Inc GILD was changed from Neutral to Overweight. Gilead Sciences earned $1.90 in the third quarter, compared to $2.65 in the year-ago quarter. The stock has a 52-week-high of $73.39 and a 52-week-low of $57.16. At the end of the last trading period, Gilead Sciences closed at $70.20.
  • For Unity Software Inc U, Piper Sandler upgraded the previous rating of Neutral to Overweight. In the second quarter, Unity Software showed an EPS of $0.18, compared to $0.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $144.69 and a 52-week-low of $26.92. Unity Software closed at $27.88 at the end of the last trading period.
  • Keybanc upgraded the previous rating for MYR Group Inc MYRG from Sector Weight to Overweight. For the third quarter, MYR Group had an EPS of $1.09, compared to year-ago quarter EPS of $1.35. The current stock performance of MYR Group shows a 52-week-high of $112.11 and a 52-week-low of $74.77. Moreover, at the end of the last trading period, the closing price was at $80.28.

See all analyst ratings upgrades.

 

Downgrades

  • For XPeng Inc XPEV, Citigroup downgraded the previous rating of Buy to Sell. For the second quarter, XPeng had an EPS of $0.43, compared to year-ago quarter EPS of $0.21. The current stock performance of XPeng shows a 52-week-high of $51.50 and a 52-week-low of $6.25. Moreover, at the end of the last trading period, the closing price was at $7.36.
  • For Core Scientific Inc CORZ, B. Riley Securities downgraded the previous rating of Buy to Neutral. In the second quarter, Core Scientific showed an EPS of $0.18, compared to $0.13 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.49 and a 52-week-low of $0.20. Core Scientific closed at $0.22 at the end of the last trading period.
  • According to Evercore ISI Group, the prior rating for Globe Life Inc GL was changed from Outperform to In-Line. Globe Life earned $2.15 in the third quarter, compared to $1.78 in the year-ago quarter. At the moment, the stock has a 52-week-high of $116.56 and a 52-week-low of $87.87. Globe Life closed at $111.91 at the end of the last trading period.
  • According to Truist Securities, the prior rating for UserTesting Inc USER was changed from Buy to Hold. In the third quarter, UserTesting showed an EPS of $0.04, compared to $0.45 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.99 and a 52-week-low of $3.31. UserTesting closed at $7.40 at the end of the last trading period.
  • Credit Suisse downgraded the previous rating for Travel+Leisure Co TNL from Outperform to Underperform. Travel+Leisure earned $1.28 in the third quarter, compared to $1.19 in the year-ago quarter. At the moment, the stock has a 52-week-high of $63.19 and a 52-week-low of $33.57. Travel+Leisure closed at $37.20 at the end of the last trading period.
  • According to Oppenheimer, the prior rating for Edwards Lifesciences Corp EW was changed from Outperform to Perform. For the third quarter, Edwards Lifesciences had an EPS of $0.61, compared to year-ago quarter EPS of $0.54. The current stock performance of Edwards Lifesciences shows a 52-week-high of $131.10 and a 52-week-low of $80.69. Moreover, at the end of the last trading period, the closing price was at $86.30.
  • According to UBS, the prior rating for The Western Union Co WU was changed from Neutral to Sell. For the second quarter, The Western Union had an EPS of $0.51, compared to year-ago quarter EPS of $0.48. At the moment, the stock has a 52-week-high of $20.40 and a 52-week-low of $13.05. The Western Union closed at $13.86 at the end of the last trading period.
  • DA Davidson downgraded the previous rating for Paylocity Holding Corp PCTY from Buy to Neutral. For the fourth quarter, Paylocity Holding had an EPS of $0.80, compared to year-ago quarter EPS of $0.46. The stock has a 52-week-high of $276.88 and a 52-week-low of $152.01. At the end of the last trading period, Paylocity Holding closed at $226.84.
  • According to William Blair, the prior rating for TriMas Corp TRS was changed from Outperform to Market Perform. In the third quarter, TriMas showed an EPS of $0.40, compared to $0.57 from the year-ago quarter. The current stock performance of TriMas shows a 52-week-high of $37.65 and a 52-week-low of $22.05. Moreover, at the end of the last trading period, the closing price was at $22.53.
  • For West Pharmaceutical Services Inc WST, B of A Securities downgraded the previous rating of Buy to Neutral. For the third quarter, West Pharmaceutical Servs had an EPS of $2.03, compared to year-ago quarter EPS of $2.06. At the moment, the stock has a 52-week-high of $468.05 and a 52-week-low of $206.19. West Pharmaceutical Servs closed at $221.23 at the end of the last trading period.
  • Exane BNP Paribas downgraded the previous rating for Axalta Coating Systems Ltd AXTA from Outperform to Neutral. In the third quarter, Axalta Coating Sys showed an EPS of $0.39, compared to $0.39 from the year-ago quarter. The current stock performance of Axalta Coating Sys shows a 52-week-high of $34.12 and a 52-week-low of $20.66. Moreover, at the end of the last trading period, the closing price was at $23.69.
  • Edward Jones downgraded the previous rating for Meta Platforms Inc META from Buy to Hold. In the third quarter, Meta Platforms showed an EPS of $1.64, compared to $3.22 from the year-ago quarter. At the moment, the stock has a 52-week-high of $199.45 and a 52-week-low of $11.73. Meta Platforms closed at $97.94 at the end of the last trading period.
  • According to Baird, the prior rating for Stanley Black & Decker Inc SWK was changed from Outperform to Neutral. Stanley Black & Decker earned $0.76 in the third quarter, compared to $2.77 in the year-ago quarter. At the moment, the stock has a 52-week-high of $196.52 and a 52-week-low of $70.24. Stanley Black & Decker closed at $75.67 at the end of the last trading period.
  • For Dana Inc DAN, RBC Capital downgraded the previous rating of Outperform to Sector Perform. Dana earned $0.24 in the third quarter, compared to $0.41 in the year-ago quarter. At the moment, the stock has a 52-week-high of $25.51 and a 52-week-low of $11.17. Dana closed at $16.03 at the end of the last trading period.
  • According to Deutsche Bank, the prior rating for Caterpillar Inc CAT was changed from Buy to Hold. Caterpillar earned $3.95 in the third quarter, compared to $2.66 in the year-ago quarter. The current stock performance of Caterpillar shows a 52-week-high of $237.90 and a 52-week-low of $160.60. Moreover, at the end of the last trading period, the closing price was at $212.14.
  • For L3Harris Technologies Inc LHX, Raymond James downgraded the previous rating of Outperform to Market Perform. In the third quarter, L3Harris Technologies showed an EPS of $3.26, compared to $3.21 from the year-ago quarter. The current stock performance of L3Harris Technologies shows a 52-week-high of $279.71 and a 52-week-low of $206.04. Moreover, at the end of the last trading period, the closing price was at $252.80.

See all analyst ratings downgrades.

 

Initiations

  • EF Hutton initiated coverage on Enovix Corp ENVX with a Buy rating. The price target for Enovix is set to $25.00. In the second quarter, Enovix showed an EPS of $0.13, compared to $0.21 from the year-ago quarter. The stock has a 52-week-high of $28.17 and a 52-week-low of $7.26. At the end of the last trading period, Enovix closed at $18.10.
  • National Bank Of Canada initiated coverage on Alithya Group Inc ALYA with a Sector Perform rating. The price target for Alithya Group is set to $3.25. For the first quarter, Alithya Group had an EPS of $0.03, compared to year-ago quarter EPS of $0.02. The stock has a 52-week-high of $3.09 and a 52-week-low of $1.69. At the end of the last trading period, Alithya Group closed at $1.79.
  • BTIG initiated coverage on MariMed Inc MRMD with a Buy rating. The price target for MariMed is set to $0.85. For the second quarter, MariMed had an EPS of $0.00, compared to year-ago quarter EPS of $0.02. The stock has a 52-week-high of $0.94 and a 52-week-low of $0.40. At the end of the last trading period, MariMed closed at $0.53.
  • JP Morgan initiated coverage on Physicians Realty Trust DOC with a Neutral rating. The price target for Physicians Realty Trust is set to $17.00. Physicians Realty Trust earned $0.27 in the second quarter, compared to $0.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of $19.12 and a 52-week-low of $13.42. Physicians Realty Trust closed at $14.77 at the end of the last trading period.
  • With a Buy rating, B. Riley Securities initiated coverage on AST SpaceMobile Inc ASTS. The price target seems to have been set at $15.00 for AST SpaceMobile. For the second quarter, AST SpaceMobile had an EPS of $0.06, compared to year-ago quarter EPS of $0.39. At the moment, the stock has a 52-week-high of $14.27 and a 52-week-low of $4.84. AST SpaceMobile closed at $5.91 at the end of the last trading period.
  • With a Neutral rating, B. Riley Securities initiated coverage on Mirati Therapeutics Inc MRTX. The price target seems to have been set at $72.00 for Mirati Therapeutics. For the second quarter, Mirati Therapeutics had an EPS of $3.18, compared to year-ago quarter EPS of $3.23. The stock has a 52-week-high of $151.15 and a 52-week-low of $32.96. At the end of the last trading period, Mirati Therapeutics closed at $66.38.
  • BTIG initiated coverage on Ascend Wellness Holdings Inc AAWH with a Buy rating. The price target for Ascend Wellness Holdings is set to $4.00. The stock has a 52-week-high of $6.76 and a 52-week-low of $1.52. At the end of the last trading period, Ascend Wellness Holdings closed at $2.00.
  • HC Wainwright & Co. initiated coverage on Eliem Therapeutics Inc ELYM with a Buy rating. The price target for Eliem Therapeutics is set to $6.00. Eliem Therapeutics earned $0.56 in the second quarter, compared to $3.11 in the year-ago quarter. The stock has a 52-week-high of $13.74 and a 52-week-low of $2.52. At the end of the last trading period, Eliem Therapeutics closed at $3.03.
  • With a Buy rating, Goldman Sachs initiated coverage on CinCor Pharma Inc CINC. The price target seems to have been set at $67.00 for CinCor Pharma. For the second quarter, CinCor Pharma had an EPS of $0.56, compared to year-ago quarter EPS of $4.81. At the moment, the stock has a 52-week-high of $43.15 and a 52-week-low of $13.00. CinCor Pharma closed at $32.72 at the end of the last trading period.
  • With an Outperform rating, Wedbush initiated coverage on Geron Corp GERN. The price target seems to have been set at $5.00 for Geron. Geron earned $0.07 in the second quarter, compared to $0.09 in the year-ago quarter. The current stock performance of Geron shows a 52-week-high of $3.06 and a 52-week-low of $0.99. Moreover, at the end of the last trading period, the closing price was at $2.30.
  • Wedbush initiated coverage on Imago BioSciences Inc IMGO with an Outperform rating. The price target for Imago BioSciences is set to $25.00. Imago BioSciences earned $0.41 in the second quarter, compared to $8.13 in the year-ago quarter. At the moment, the stock has a 52-week-high of $27.04 and a 52-week-low of $11.56. Imago BioSciences closed at $16.53 at the end of the last trading period.

See all analyst ratings initiations.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...